Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, District of Columbia.
Department of Medicine, Georgetown University, Washington, District of Columbia.
Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F572-F583. doi: 10.1152/ajprenal.00512.2018. Epub 2019 Jun 26.
Many studies have suggested that renal T cell infiltration contributes to the pathogenesis of salt-sensitive hypertension. To investigate this mechanism further, we determined T cell profiles in the kidney and lymphoid tissues as a function of blood pressure in the female Envigo Dahl salt-sensitive (SS) rat maintained on low-Na (LS) diet. Mean arterial pressure and heart rate were measured by telemetry in SS rats from 1 mo old (juvenile) to 4 mo old. Normotensive salt-resistant (SR) rats were included as controls. Frequencies of T helper (CD4) cells were greater in the kidney, lymph nodes, and spleen in 4-mo-old hypertensive SS rats compared with normotensive SR animals and SS juvenile rats, suggesting that renal T cell infiltration contributes to hypertension in the SS rat on a LS diet. At 1.5 mo, half of the SS rats were treated with vehicle (Veh), and the rest received hydralazine (HDZ; 25 mg·kg·day) for 11 wk. HDZ impeded the development of hypertension compared with Veh-treated control rats [mean arterial pressure: 157 ± 4 mmHg in the Veh-treated group ( = 6) vs. 133 ± 3 mmHg in the HDZ-treated group ( = 7), < 0.001] without impacting T helper cell frequencies in the tissues, suggesting that HDZ can overcome mechanisms of hypertension driven by renal T cell infiltration under the LS diet. Renal frequencies of CD4CD25 and CD4CD25FoxP3 regulatory T cells were significantly higher in 4-mo-old hypertensive rats compared with normotensive SR rats and SS juvenile rats, suggesting that these T cell subpopulations play a compensatory role in the development of hypertension. Greater understanding of these T cell populations could lead to new therapeutic targets for treating inflammatory diseases associated with hypertension.
许多研究表明,肾脏 T 细胞浸润有助于盐敏感型高血压的发病机制。为了进一步研究这一机制,我们确定了女性 Envigo 达尔盐敏感(SS)大鼠在低钠(LS)饮食下血压变化时肾脏和淋巴组织中的 T 细胞谱。通过遥测法测量 SS 大鼠从 1 个月大(幼年)到 4 个月大时的平均动脉压和心率。将血压正常的盐抵抗(SR)大鼠作为对照。与血压正常的 SR 动物和 SS 幼鼠相比,4 个月大的高血压 SS 大鼠肾脏、淋巴结和脾脏中的 T 辅助(CD4)细胞频率更高,提示 LS 饮食下 SS 大鼠的肾脏 T 细胞浸润有助于高血压的发生。在 1.5 个月时,一半的 SS 大鼠接受载体(Veh)治疗,其余的接受肼屈嗪(HDZ;25mg·kg·day)治疗 11 周。与 Veh 治疗的对照组相比,HDZ 可阻止高血压的发展[平均动脉压:Veh 治疗组为 157±4mmHg( = 6),HDZ 治疗组为 133±3mmHg( = 7),<0.001],而不影响组织中 T 辅助细胞频率,提示 HDZ 可克服 LS 饮食下由肾脏 T 细胞浸润驱动的高血压机制。与血压正常的 SR 大鼠和 SS 幼鼠相比,4 个月大的高血压大鼠肾脏中 CD4CD25 和 CD4CD25FoxP3 调节性 T 细胞的频率显著升高,提示这些 T 细胞亚群在高血压的发生发展中起代偿作用。对这些 T 细胞群体的进一步了解可能为治疗与高血压相关的炎症性疾病提供新的治疗靶点。